Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
| CASTLE BIOSCIENCES INCCSTL · Entity 359 | Director | July 16, 2020 | July 28, 2020 |
| VERACYTE, INC.VCYT · Entity 2018 | Director | June 02, 2023 | June 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,847 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 17,847 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
CASTLE BIOSCIENCES INC
Report date July 16, 2020 · Filed July 28, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy trust | 21,723 |
Last balance in matching sequence
After 2020-07-16 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-07-16 · Sale · Disposed 1,228 · Balance 23,495 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 2 · 2020-07-16 · Sale · Disposed 1,763 · Balance 21,732 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. Row 3 · 2020-07-16 · Sale · Disposed 9 · Balance 21,723 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020. F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
F2: This transaction was executed in multiple trades at prices ranging from $42.51 to $43.14, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
F4: This transaction was executed in multiple trades at prices ranging from $43.61 to $44.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
VERACYTE, INC.
Report date June 02, 2023 · Filed June 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,377 |
Reported balance
After 2023-06-02 transaction · row 1
1 source rowRow 1 · 2023-06-02 · Tax withholding · Disposed 1,304 · Balance 41,377 F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectThe Bonnie H. Anderson Living Trust | 134,800 |
Reported balance
Holding disclosure · report date 2023-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 134,800 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 812 and 492 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,062 and 1,250 Restricted Stock Units, respectively, granted on February 28, 2020 and February 26, 2021, respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2020 Filed Mar 23, 2020 21:01 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-20-000043 · wf-form4_158499725312617.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,313 Underlying: Common Stock · 16,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 21:01 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 16,000 | $2.68 | $42,880.00 |
DisclosureSEC source: 0001384101-20-000043 · wf-form4_158499725312617.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,241 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $25.18 | $503,520.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,313 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 21:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000041 · wf-form4_158396070314703.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 4,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000029 · wf-form4_158327587188563.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,313 F2 · kind: Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 192,500 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001384101-20-000029 · wf-form4_158327587188563.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,500 Underlying: Common Stock · 192,500 shares Expires 2030-02-27 F3 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000029 · wf-form4_158327587188563.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,250 F1 · kind: Restricted stock units awarded on February 28, 2020 which vest 25% on March 2, 2021 and 1/16 per quarter thereafter, based on continuing services on each vesting date. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:13 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 39,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000021 · wf-form4_158275155976931.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,250 F2 · kind: The reporting person is reporting the withholding of 39,488 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 75,000 Performance Stock Units vested on February 24, 2020 and does not represent a sale by the reporting person. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:13 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000021 · wf-form4_158275155976931.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,738 F1 · kind: Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2019, as reflected in the financial statements certified by the Audit Committee of the Board of Directors on February 24, 2020. The RSUs vested as to 50% of the total RSUs earned on February 24, 2020, and the remaining 50% of the RSUs will vest on February 24, 2021, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000002 · wf-form4_157895057977644.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,241 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $28.86 | $577,276.00 |
DisclosureSEC source: 0001384101-20-000002 · wf-form4_157895057977644.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,738 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.62 to $29.15. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-20-000002 · wf-form4_157895057977644.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000166 · wf-form4_157610076486955.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,313 Underlying: Common Stock · 15,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000166 · wf-form4_157610076486955.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,241 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 15,000 | $2.68 | $40,200.00 |
DisclosureSEC source: 0001384101-19-000166 · wf-form4_157610076486955.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $28.96 | $579,248.00 |
DisclosureSEC source: 0001384101-19-000166 · wf-form4_157610076486955.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,738 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.27 to $29.25. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:46 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-19-000166 · wf-form4_157610076486955.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:18 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 988 | $27.19 | $26,863.72 |
DisclosureSEC source: 0001384101-19-000148 · wf-form4_157549429418203.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,738 F1 · shares: The reporting person is reporting the withholding of 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000136 · wf-form4_157411197089300.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,241 Underlying: Common Stock · 20,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $25.06 | $501,124.00 |
DisclosureSEC source: 0001384101-19-000136 · wf-form4_157411197089300.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,726 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.22. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001384101-19-000136 · wf-form4_157411197089300.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 2,259 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000128 · wf-form4_157082552609526.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,241 Underlying: Common Stock · 2,259 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 5,041 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000128 · wf-form4_157082552609526.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,041 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $24.50 | $196,004.80 |
DisclosureSEC source: 0001384101-19-000128 · wf-form4_157082552609526.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,726 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.28 to $24.85. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 2,259 | $4.00 | $9,036.00 |
DisclosureSEC source: 0001384101-19-000128 · wf-form4_157082552609526.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 5,041 | $2.68 | $13,509.88 |
DisclosureSEC source: 0001384101-19-000128 · wf-form4_157082552609526.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 21:45 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,815 | $25.04 | $120,560.38 |
DisclosureSEC source: 0001384101-19-000122 · wf-form4_156832469879109.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,426 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.80 to $25.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 21:45 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,787 | $24.08 | $43,025.96 |
DisclosureSEC source: 0001384101-19-000122 · wf-form4_156832469879109.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,241 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $23.72 to $24.71. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 21:45 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,398 | $23.27 | $32,527.69 |
DisclosureSEC source: 0001384101-19-000122 · wf-form4_156832469879109.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,028 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $22.69 to $23.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 21:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 988 | $25.09 | $24,788.92 |
DisclosureSEC source: 0001384101-19-000112 · wf-form4_156771802941012.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,426 F1 · shares: The reporting person is reporting the withholding of 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,459 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000106 · wf-form4_156573047353478.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,041 Underlying: Common Stock · 1,459 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $25.28 | $202,236.80 |
DisclosureSEC source: 0001384101-19-000106 · wf-form4_156573047353478.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,414 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.11 to $25.94. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,459 | $2.68 | $3,910.12 |
DisclosureSEC source: 0001384101-19-000106 · wf-form4_156573047353478.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:20 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionSeries F Preferred Stock · Derivative | 17,180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043854 · doc4.xml · derivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F1 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 20:20 UTC | CASTLE BIOSCIENCES INC CSTL · Entity 359 | ConversionCommon Stock | 14,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043854 · doc4.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 14,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date. F2 · ownership.nature: Held by the Bonnie H. Anderson Living Trust. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 147 | $29.41 | $4,323.68 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $29.40 to $29.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 7,853 | $28.78 | $225,990.49 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,102 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.40 to $29.39. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 10, 2019 Filed Jul 11, 2019 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000096 · wf-form4_156287891380081.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · derivative · entry 4 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,000 | $26.33 | $210,635.20 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.05 to $26.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 20:36 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,000 | $2.68 | $21,440.00 |
DisclosureSEC source: 0001384101-19-000068 · wf-form4_156028538630084.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 18,125 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · derivative · entry 6 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,125 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 7,526 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,526 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 18,125 | $2.36 | $42,775.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 7,526 | $2.36 | $17,761.36 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 2 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:21 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000058 · wf-form4_155976608887268.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,304 F1 · shares: The reporting person is reporting the withholding of 988 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,875 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · derivative · entry 5 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 8,000 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:28 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,340 | $23.52 | $55,045.22 |
DisclosureSEC source: 0001384101-19-000056 · wf-form4_155777927395659.xml · nonDerivative · entry 3 Anderson Bonnie H · CIK 0001588970 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,292 F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $23.34 to $23.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.